Wearable Patch Ultrasound vs FibroScan: Prospective Trial to Validate Point-of-Care Liver Fibrosis Detection — What Clinicians Need to Know

References

1. 1.Second Affiliated Hospital of Xi'an Jiaotong University. (2025). Diagnostic accuracy of a wearable patch-type ultrasound probe for detecting liver fibrosis and cirrhosis: A prospective cross-sectional study (NCT07716384). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07716384
2. 2.MacLachlan, J. H., & Cowie, B. C. (2015). Hepatitis B virus epidemiology. Cold Spring Harbor Perspectives in Medicine, 5(5), a021410. https://doi.org/10.1101/cshperspect.a021410
3. 3.European Association for the Study of the Liver. (2021). EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. Journal of Hepatology, 75(3), 659–689. https://doi.org/10.1016/j.jhep.2021.05.025
4. 4.Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., Kressel, H. Y., Rifai, N., Golub, R. M., Altman, D. G., Hooft, L., Korevaar, D. A., & Cohen, J. F. (2015). STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies. BMJ, 351, h5527. https://doi.org/10.1136/bmj.h5527
5. 5.Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease — meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73–84. https://doi.org/10.1002/hep.28431